Gore Carotid Stent

Stent, Carotid

FDA Premarket Approval P180010

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the gore® carotid stent, used with the gore® embolic filter. The device is indicated for the treatment of carotid artery stenosis in patients deemed at high surgical risk for carotid endarterectomy (cea) and who meet the criteria below. 1) patients with symptomatic carotid artery stenosis, >= 50%, as confirmed by ultrasound or angiography;2) patients with asymptomatic carotid artery stenosis, >=80%, as confirmed by ultrasound or angiography; and 3) patients must have a reference vessel diameter of 3. 7 mm to 9. 0 mm.

DeviceGore Carotid Stent
Classification NameStent, Carotid
Generic NameStent, Carotid
ApplicantW. L Gore & Associates, Inc
Date Received2018-03-23
Decision Date2018-11-01
Notice Date2018-11-07
PMAP180010
SupplementS
Product CodeNIM
Docket Number18M-4205
Advisory CommitteeCardiovascular
Expedited ReviewNo
Combination Product Yes
Applicant Address W. L Gore & Associates, Inc 4250 W. Kiltie Lane flagship, AZ 86005
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P180010Original Filing
S004 2019-03-01 30-day Notice
S003 2019-02-04 30-day Notice
S002
S001 2018-11-15 30-day Notice

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.